About Associate Professor Gregory Fox

Associate Professor Fox's research interests include the epidemiology of infectious disease in resource-limited setting, cluster randomized trials, clinical trials and digital technologies to support health care. He also has interests in systematic reviews and meta-analyses, translation of evidence into policy, decision analysis and capacity building in research.

Associate Professor Fox's teaching interests including drug resistant TB, design and implementation of clinical trials, meta-analysis and clinical epidemiology. He leads the Clinical Teaching Fellowship Program within the Faculty of Medicine and Health, that equips leaders in education with the skills required to contribute to teaching in healthcare settings.

Current projects include:
A randomised controlled trial evaluating the effect of a community-based intervention to reduce antimicrobial use in Vietnam (the V-RESIST Trial)
A clinical trial of preventive therapy for mult-drug resistant tuberculosis in Vietnam (the VQUIN MDR Trial)
Improving the management of chronic lung disease (asthma and COPD), and tobacco control in resource limited settings (The VCAPS Study)
A cluster randomised trial of community-based screening for TB in rural community (the ACT3 study)
Reducing the gap between policy and practice: strengthening preventive therapy for TB in 5 countries (the ACT4 study)
Evaluating relapse of TB among patients treated with standardised therapy in Vietnam

Selected publications

• Visser, S., Bye, P., Fox, G., Burr, L., Chang, A., Holmes-Liew, C., King, P., Middleton, P., Maguire, G., Smith, D., Britton, W., Morgan, L., et al (2019). Australian adults with bronchiectasis: The first report from the Australian Bronchiectasis Registry. Respiratory Medicine, 155, 97-103. [More Information]
• Phuong, N., Anh, N., Son, N., Sintchenko, V., Ho, J., Fox, G., Nhung, N., Marks, G. (2019). Effect of two alternative methods of pooling sputum prior to testing for tuberculosis with genexpert MTB/RIF. BMC Infectious Diseases, 19(1), 1-4. [More Information]
• Oxlade, O., Trajman, A., Benedetti, A., Adjobimey, M., Cook, V., Fisher, D., Fox, G., Fregonese, F., Hadisoemarto, P., Hill, P., et al (2019). Enhancing the public health impact of latent tuberculosis infection diagnosis and treatment (ACT4): protocol for a cluster randomised trial. BMJ Open, 9(3), 1-10. [More Information]
• Lung, T., Marks, G., Nhung, N., Anh, N., Hoa, N., Anh, L., Hoa, N., Britton, W., Bestrashniy, J., Jan, S., Fox, G. (2019). Household contact investigation for the detection of tuberculosis in Vietnam: economic evaluation of a cluster-randomised trial. The Lancet Global Health, 7(3), e376-e384. [More Information]
• Fox, G., Dodd, P., Marais, B. (2019). Household contact investigation to improve tuberculosis control. The Lancet Infectious Diseases, 19(3), 235-237. [More Information]
• Drabarek, D., Anh, N., Nhung, N., Hoa, N., Fox, G., Bernays, S. (2019). Implementation of Medication Event Reminder Monitors among patients diagnosed with drug susceptible tuberculosis in rural Viet Nam: A qualitative study. PloS One, 14(7), e0219891. [More Information]
• Romanowski, K., Baumann, B., Basham, C., Khan, F., Fox, G., Johnston, J. (2019). Long-term all-cause mortality in people treated for tuberculosis: a systematic review and meta-analysis. The Lancet Infectious Diseases, 19(10), 1129-1137. [More Information]
• Keshavjee, S., Amanullah, F., Cattamanchi, A., Chaisson, R., Dobos, K., Fox, G., Gendelman, H., Gordon, R., Hesseling, A., Le Van, H., et al (2019). Moving toward Tuberculosis Elimination Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection. American Journal of Respiratory and Critical Care Medicine, 199(5), 564-571. [More Information]
• Fox, G., Nguyen, V., Dinh, N., Nghiem, L., Le, T., Nguyen, T., Nguyen, B., Tran, N., Nguyen, T., Le, T., Ho, J., Britton, W., et al (2019). Post-treatment Mortality Among Patients With Tuberculosis: A Prospective Cohort Study of 10 964 Patients in Vietnam. Clinical Infectious Diseases, 68(8), 1359-1366. [More Information]
• Kendall, E., Sahu, S., Pai, M., Fox, G., Varaine, F., Cox, H., Cegielski, J., Mabote, L., Vassall, A., Dowdy, D. (2019). What will it take to eliminate drug-resistant tuberculosis? International Journal of Tuberculosis and Lung Disease, 23(5), 535-546. [More Information